4//SEC Filing
EDWARDS MARK G 4
Accession 0001209191-19-047417
CIK 0001427925other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 4:52 PM ET
Size
10.0 KB
Accession
0001209191-19-047417
Insider Transaction Report
Form 4
EDWARDS MARK G
Director
Transactions
- Purchase
Common Stock
2019-08-23$2.20/sh+10,000$21,956→ 213,750 total - Purchase
Common Stock
2019-08-26$2.17/sh+5,000$10,850→ 218,750 total
Footnotes (1)
- [F1]The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $2.185 to $2.20 on August 23, 2019. The reporting person will provide upon request to the SEC, the issuer or security holder of Issuer, full information regarding the number of shares purchased at each separate price.
Issuer
ACELRX PHARMACEUTICALS INC
CIK 0001427925
Entity typeother
Related Parties
1- filerCIK 0001190429
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 4:52 PM ET
- Size
- 10.0 KB